相关实验视频
Updated: Jun 10, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.1K
从韩国妇科瘤组的开始到现在和下一步
Kyung-Jin Min1, Nam Kyeong Kim1, Jae-Yun Song2
1Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Ansan 15355, Republic of Korea.
Cancers
|October 16, 2024
概括
韩国妇科瘤学集团 (KGOG) 推动妇科癌症的多中心临床试验,促进研究和国际合作. 在KGOG的KGOG.
科学领域:
- 妇科瘤学 妇科瘤学
- 临床试验 临床试验
- 癌症研究 癌症研究
背景情况:
- 韩国妇科瘤学集团 (KGOG) 成立于2002年,是韩国为多中心妇科癌症试验的唯一组织.
- 在2021年重新建立为非营利组织,KGOG现在包括76家医院的207名专家.
- KGOG专注于罕见疾病和妇科癌症研究,增强机构能力和信息共享.
研究的目的:
- 提供韩国妇科瘤学集团 (KGOG) 的历史,现状和未来研究方向的概述.
- 突出KGOG致力于通过多中心临床研究和国际合作推动妇科瘤学的承诺.
- 展示KGOG对该领域临床试验和出版物的重大贡献.
主要方法:
- 通过加入美国妇科瘤学小组 (GOG) 和妇科癌症跨组 (GCIG),KGOG积极参与国际试验.
- 该组织每两年举办一次会议,研讨会和众多运营委员会会议,以审查和讨论研究.
- 迄今为止,KGOG已经进行了156项由研究人员发起的试验 (IIT) 和由赞助商发起的试验 (SIT),有18项研究已注册,10项正在准备中.
主要成果:
- KGOG已经发表了68篇论文,目前参与了6个国家项目.
- 该集团与包括NRG瘤学基金会,GOG合作伙伴,GCIG,EAGOT和JGOG在内的国际组织建立了合作关系.
- 在2023年,KGOG举办了第一个子宫内膜癌共识会议-临床研究 (ECCC-CR),加强了其研究能力.
结论:
- 通过国际合作伙伴关系,KGOG显著扩大了其研究范围,并取得了显著的临床成果.
- 该组织致力于推进妇科瘤学研究和患者护理.
- 肯德基的未来方向有可能在该领域取得重大突破和进步.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Hormonal Control of the Ovarian Cycle
426
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
426
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Disorders of the Female Reproductive System
333
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
333
Infertility in Females
288
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
288

